Trials / Sponsors / Cancer Prevention Pharmaceuticals, Inc.
Cancer Prevention Pharmaceuticals, Inc.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | Urinary Biomarker Study With Sulindac and Difluoromethylornithine Focus of Study: Drug Response Biomarkers, Chemoprevention, Neoplasms | Phase 2 | 2014-03-01 |
| Completed | Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP) Familial Adenomatous Polyposis | Phase 3 | 2013-10-01 |
| Withdrawn | A Trial of Low Dose Sulindac Combined With Eflornithine in Patients With Familial Adenomatous Polyposis (FAP) Familial Adenomatous Polyposis | Phase 3 | 2011-03-01 |